After nearly 100 years, one of the most common hormone disorders affecting women has officially been renamed. Following a 14 year international effort involving more than 22,000 patients, researchers, and medical experts, Polycystic Ovary Syndrome (PCOS) is now being called Polyendocrine Metabolic Ovarian Syndrome (PMOS).

Why does that matter?

Because the new name finally reflects what science has been telling us for years, this is a whole body hormonal and metabolic condition, not simply an ovarian disorder.

In this episode, we break down:

• Why PCOS was officially renamed PMOS and what prompted the historic change

• What the new name tells us about hormones, insulin resistance, and metabolism

• Why up to 70% of women with PMOS remain undiagnosed

• The four different types of PMOS patients we commonly see in clinic

• The long term health risks that extend far beyond fertility and irregular periods

• Why treatment needs to focus on both hormone balance and metabolic health

One of the biggest takeaways from this episode is that you probably know someone living with PMOS, whether they realize it or not. The condition affects up to 1 in 7 women of reproductive age, making it one of the most common endocrine disorders in women.

Understanding the new name isn't just about changing terminology. It's about changing the conversation, improving diagnosis, reducing stigma, and helping women receive the care they deserve.

Share this with a friend because chances are... you have a friend with PMOS.

#HumpDayHormones #PMOS #PCOS #HormoneHealth #InsulinResistance #WomensHealth #MetabolicHealth #EndocrineHealth #HormoneEducation #WomensWellness